This Week In The Bmj
Interferon alfa plus ribavirin combination therapy benefits patients with chronic hepatitis C
BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7322.0 (Published 17 November 2001) Cite this as: BMJ 2001;323:0Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.